NCT00006361View on ClinicalTrials.gov

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2000

Primary Completion Date

January 31, 2003

Conditions
Carcinoma of Unknown PrimaryHead and Neck CancerNon-melanomatous Skin Cancer
Interventions
DRUG

semaxanib

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00006361 - SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck | Biotech Hunter | Biotech Hunter